Monday, November 09, 2020 3:41:14 PM
(Oslo, 09 November, 2020) Nel Hydrogen U.S., the U.S. subsidiary of Nel ASA (Nel, OSE:NEL), has received purchase orders for PEM electrolyser cell stacks from Raytheon Technologies´ Collins Aerospace Division, at a combined value of more than USD 5.4 million. Nel’s electrolyser stacks produce critical life support oxygen for U.S. Navy crews on multiple classes of nuclear-powered submarines and are being delivered under an exclusive contract.
“We are very proud to work with our partner Collins Aerospace and the U.S. Navy on this mission critical application for PEM electrolysis. This new order demonstrates the continuing success of our world class manufacturing and quality systems, as well as the reliability of our industry leading PEM electrolyser technology” says Steve Szymanski, Vice President of Sales & Marketing at Nel Hydrogen U.S.
The purchase order is part of an ongoing production contract with Collins Aerospace, and continues Nel’s history of supplying PEM electrolyser stacks for the production of life sustaining oxygen on board Navy submarines for over a decade. During the first half of 2020, Nel received additional orders for Navy stacks worth over $3.7M, bringing the total booked orders this year to over $9.1M.
“The U.S. Navy is now exclusively buying PEM electrolysers for oxygen production on submarines, based on its long track record of reliability and safety, and Nel is now the world’s leading supplier of cell stacks for this application,” Szymanski concludes.
https://nelhydrogen.com/press-release/nel-asa-receives-purchase-orders-for-u-s-navy-pem-electrolyser-stacks/
>>> Trip Advisor IS A GROWING STOCK PICK BOARD NOW <<< *** I take PLUS1 donations *** PREeBCGQKPrikA4C1DmrAizAHFDoiiUZA2
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM